Identifizierung und Selektion von Chondroitinsulfatpflanzen und Ihre Verwendung
EP4721763
8. April 2026
Anmelder: Vivatis Pharma GmbH 🇩🇪
Details
- Veröffentlichungs-Nr.
- EP4721763
- Anmeldetag
- 8. Juni 2020
- Veröffentlichung
- 8. April 2026
- Rechtsraum
- EP
- IPC
- A61K47/36(YANG SHU-HUI et al.)no. 24634-61-5
Abstract
Process for extraction from a plant starting material, such as a fungus, for the preparation of a mixture (m) comprising or, alternatively, consisting of at least one glycosaminoglycan selected from: (a) hyaluronic acid or a salt thereof (HA) having a weight average molecular weight of comprised from 10 kDa to 600 kDa; (b) chondroitin or chondroitin sulfate or a salt thereof (CS) having a weight average molecular weight comprised from 3 kDa to 50 kDa; and (c) a combination of (a) and (b).
Anmelder
- Firma
- Vivatis Pharma GmbH
- Land
- 🇩🇪 Deutschland
Fachgebiete
Vertreten von
-
Marben S.r.l
Marben S.r.l · Milano